Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06476223

Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia

Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hemodialysis patients with xerostomia are divided into 2 groups which are group A (start with artificial saliva containing cumin and ginger extract for 2 weeks, free periods 2 weeks, then placebo for 2 weeks) and group B (start with placebo for 2 weeks, free periods 2 weeks, then artificial saliva containing cumin and ginger extract for 2 weeks). Amount of saliva (g/min), xerostomia's questionnaire, Increase of saliva score, World Health Organization Oral Mucositis Grading Scale, acid and base of saliva, quality of life's questionnaire will measure before, after using the sample for 7 and 14 days.

Conditions

Interventions

TypeNameDescription
DRUGArtificial saliva containing cumin and ginger extractThe sample will be sprayed 2 puff/time, 3 times/day, for 14 days.
DRUGPlaceboThe sample will be sprayed 2 puff/time, 3 times/day, for 14 days.

Timeline

Start date
2024-07-01
Primary completion
2024-12-30
Completion
2025-01-31
First posted
2024-06-26
Last updated
2024-07-01

Source: ClinicalTrials.gov record NCT06476223. Inclusion in this directory is not an endorsement.

Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia (NCT06476223) · Clinical Trials Directory